97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2011-003208-19-CZ
(EUCTR)
05/09/201303/04/2013GWP42003 symptomatic treatment of ulcerative colitis.A randomised, double-blind, placebo-controlled parallel group, pilot study of GWP42003 in the symptomatic treatment of ulcerative colitis. Symptoms of diarrhoea, rectal bleeding, stool frequency and inflammation in subjects with ulcerative colitis
MedDRA version: 16.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Code: GWP42003
INN or Proposed INN: Not Applicable
Other descriptive name: CANNABIDIOL
GW Pharma Ltd.NULLNot RecruitingFemale: yes
Male: yes
62Phase 2Czech Republic;United Kingdom
2NCT01562314
(ClinicalTrials.gov)
May 9, 201221/3/2012A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)A Randomised, Double-blind, Placebo-controlled Parallel Group, Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative ColitisUlcerative ColitisDrug: GWP42003;Drug: PlaceboGW Research LtdNULLCompleted18 YearsN/AAll60Phase 2United Kingdom;Czech Republic
3EUCTR2011-003208-19-GB
(EUCTR)
16/11/201128/09/2011GWP42003 symptomatic treatment of ulcerative colitis.A randomised, double-blind, placebo-controlled parallel group, pilot study of GWP42003 in the symptomatic treatment of ulcerative colitis. Symptoms of diarrhoea, rectal bleeding, stool frequency and inflammation in subjects with ulcerative colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Code: GWP42003
INN or Proposed INN: Not applicable
Other descriptive name: CANNABIDIOL
GW Pharma Ltd.NULLNot Recruiting Female: yes
Male: yes
62 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): noCzech Republic;United Kingdom